ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

QLGN Qualigen Therapeutics Inc

0.284499
0.00 (0.00%)
2024年5月13日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Qualigen Therapeutics Inc QLGN NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 0.284499 09:00:00
始値 安値 高値 終値 前日終値
0.284499
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0409:59EDGAR2Form S-1/A - General form for registration of securities..
2024/4/1620:00GLOBEMarizyme Enters Into Co-Development Agreement With Qualigen..
2024/4/1021:00GLOBEQualigen Therapeutics' Novel Direct Pan-RAS Inhibitors..
2024/4/0921:00GLOBEQualigen Therapeutics Announces Poster Featuring Positive..
2024/2/2721:00EDGAR2Form 8-K - Current report
2024/2/2306:10EDGAR2Form 8-K - Current report
2023/12/0806:15EDGAR2Form 8-K - Current report
2023/11/2306:30EDGAR2Form 8-K - Current report
2023/11/1506:30GLOBEQualigen Therapeutics Provides Corporate Update for Third..
2023/11/0904:16EDGAR2Form 8-K - Current report
2023/11/0722:30GLOBEQualigen Therapeutics Announces First Patient Dosed in the..
2023/10/2321:30GLOBEPoster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor..
2023/10/1721:30EDGAR2Form 8-K - Current report
2023/9/2905:15EDGAR2Form 8-K - Current report
2023/9/2721:30GLOBEQualigen Therapeutics Presents Scientific Data on QN-302 at..
2023/9/0813:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/9/0205:15EDGAR2Form POS AM - Post-Effective amendments for registration..
2023/8/1721:30GLOBEQualigen Therapeutics Partners with TD2 for Phase 1 Clinical..
2023/8/1523:04EDGAR2Form 8-K - Current report
2023/8/1521:30GLOBEQualigen Therapeutics, Inc. Reports Financial Results and..
2023/8/1505:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0505:30EDGAR2Form 8-K - Current report
2023/8/0121:35EDGAR2Form 8-K - Current report
2023/8/0121:30GLOBEQualigen Therapeutics Announces US FDA IND Clearance to..
2023/7/2706:25EDGAR2Form 8-K - Current report
2023/7/2421:15GLOBEQualigen Therapeutics Divests FastPack® Diagnostics Business
2023/7/1406:29EDGAR2Form 8-K - Current report
2023/7/0806:08EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
2023/6/0521:15GLOBEPoster Highlighting Qualigen Therapeutics’ Pan-RAS Inhibitor..
2023/5/1621:00GLOBEQualigen Therapeutics, Inc. Reports Financial Results and..

最近閲覧した銘柄

Delayed Upgrade Clock